These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of ciladopa on Parkinson's disease: a preliminary report. Weiner WJ; Berger JR Adv Neurol; 1987; 45():583-6. PubMed ID: 3548268 [No Abstract] [Full Text] [Related]
6. [Nursing process: nursing of patients with Parkinson's disease. Nursing before and after withdrawal for the purpose of medication control of patients with Parkinson's disease]. Kanagawa M; Osaga W; Ishii T; Saika M; Ishii T Kurinikaru Sutadi; 1985 Aug; 6(8):933-9. PubMed ID: 3850295 [No Abstract] [Full Text] [Related]
7. [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)]. Gründig E; Gerstenbrand F Wien Klin Wochenschr; 1980 Dec; 92(24):868-71. PubMed ID: 7222702 [TBL] [Abstract][Full Text] [Related]
8. [Use of methamidoline in the treatment of parkinson-like manifestations due to neuroleptics]. Arnone A; Parodi A Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1126-42. PubMed ID: 5143724 [No Abstract] [Full Text] [Related]
9. Combined treatment in Parkinson's disease. Wheatley D Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232 [No Abstract] [Full Text] [Related]
10. Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings. Spieker S; Löschmann P; Jentgens C; Boose A; Klockgether T; Dichgans J Clin Neuropharmacol; 1995 Jun; 18(3):266-72. PubMed ID: 8635185 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic indications in Parkinson's disease]. Petit H LARC Med; 1983; 3(6):433-5. PubMed ID: 6888113 [No Abstract] [Full Text] [Related]
12. [Preliminary clinical trial of tetrahydropapaveroline in Parkinson's disease]. Dordain G; Goujet MA; Simon P Therapie; 1974; 29(3):421-34. PubMed ID: 4612860 [No Abstract] [Full Text] [Related]
13. Preclamol and parkinsonian fluctuations. Pirtosek Z; Merello M; Carlsson A; Stern G Clin Neuropharmacol; 1993 Dec; 16(6):550-4. PubMed ID: 9377590 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategies recommended for early stage Parkinson's disease]. Derkinderen P Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():82-90. PubMed ID: 10916041 [No Abstract] [Full Text] [Related]
15. Case studies in the advancement of Parkinson's disease. Frei K; Truong DD; Wolters E CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948 [TBL] [Abstract][Full Text] [Related]